Article Figures & Data
Figures
- Figure 1.
Within-Trial Analysis at 24 Weeks: ICER for Etanercept
ICER, incremental cost-effectiveness ratio; M, million; QALY, quality-adjusted life year.
Reproduced with permission from N Bansback, PhD.
- Figure 2.
Sensitivity Analysis Showing No Cost-effectiveness With Etanercept
ETN, etanercept; HAQ, Health Assessment Questionnaire; ICER, incremental cost-effectiveness ratio; TT, triple therapy.
Reproduced with permission from N Bansback, PhD.
Tools
Triple Therapy More Cost-effective than Biologic First in Patients Who Fail MTX
Permalink:
Table of contents
Cited By...
- No citing articles found.